Supernus Pharmaceuticals reported $625.12M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Aerie Pharmaceuticals AERI:US $ 311.41M 5.56M
Ani Pharmaceuticals ANIP:US $ 322.4M 21M
Aurora Cannabis Inc ACB:CN 696.63M 92.19M
Bristol Myers Squibb BMY:US $ 30186M 65M
Canopy Growth Corp WEED:CN C$ 1.59B 143.83M
Cara Therapeutics CARA:US $ 176.17M 24.4M
Corcept Therapeutics CORT:US $ 419.04M 30.82M
Eisai 4523:JP Y 620947M 19659M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Horizon Pharma HZNP:US $ 3203.09M 255.36M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Lannett LCI:US $ 318.7M 15.91M
Marinus Pharmaceuticals MRNS:US $ 101.09M 33.98M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Supernus Pharmaceuticals SUPN:US $ 625.12M 56.6M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
United Therapeutics UTHR:US $ 2684.3M 97.7M
Xeris Pharmaceuticals Inc XERS:US $ 161.21M 16.34M